A study on siddha trail drug Muruvili Kudineer(int) in patients having Singimantha kanam
Phase 2
- Conditions
- Health Condition 1: null- Singimantha kanam(Bronchitis)
- Registration Number
- CTRI/2018/04/013286
- Lead Sponsor
- Government Siddha Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age 3-13years
Sex:Both Male and Female children
Fever
Dynpnea
Dry or Productive cough
Wheezing
Patients who are all willing to give blood samples at subsequent visit are involved in this study
Exclusion Criteria
Allergic rhinitis
Asthma
Refluxoesophagitis
Upper respiratory infections/common cold
Bronchiolitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is mainly assessed by BS Score reduction in clinical symptoms like fever, cough, sputum, dyspnea, wheezing before and after treatmentTimepoint: 7 days
- Secondary Outcome Measures
Name Time Method Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 7 days